Current standard of treatment of interferon and ribavirun has only been effective in curing 38 to 40 percent of patients with chronic hepatitis C genotype 1. In clinical trials, Victrelis and Incivek, when working in concert with interferon and ribavirun, cured 65 to 75 percent of people with chronic disease and Victrelis-alone doubled the previous cure rate among African Americans......
Victrelis (Boceprevir)
Incivek (Telaprevir)
News Release Archives > New drugs encouraging for African Americans with hepatitis C
